Skip to main content
OpenTrials
Completed

NCT Number: NCT00543153

The Exceptional Patient in Cancer Care

The objectives of this study is to conduct a multicenter, dual country (United States and Israel), study examining the experience of patients with cancer that were considered by their physicians as having exceptional course of survival related to their specific disease state.

The primary aim of the study is to develop a detailed description of patients' experience of an exceptional disease course. The secondary aim is to define the content domain for assessment and measurement of exceptional disease course in patients with cancer and identify lessons learned from these exceptional patients that can be a base for future studies to benefit others.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Tel Aviv University, Tel Aviv, Israel

Loading trial locations.

About this study

The investigators of this study are exploring the experience of people with cancer who are considered by their physicians as having an exceptional course of disease - people who have defied the odds and remain well despite the severity of the original diagnosis.

Participation in this study is completely voluntary. Lessons learned from recorded experience(s) may be helpful to other patients and can be a basis for future studies that may benefit other patients.

To participate in this important study is simple and not time consuming. You will have only one face-to-face or telephone interview with a research assistant. During the interview you will simply be asked to describe your perspective, thoughts, and behaviors that you think are related to your disease course and lessons that you think others may gain benefit from. The interview will last about one hour and will be conducted at a time that is convenient for you.

If you agree to participate a research assistant will schedule a time for a recorded interview by phone or if possible at a location convenient to you. The interviews will be taped and transcribed. All recorded interviews will be retained for a minimum of 6 years.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 18 years of age or older
  • Ability to speak and read English with patients residing in the US, ability to speak and read Hebrew with patients residing in Israel.
  • Diagnosis of cancer confirmed by pathology.
  • Exceptional disease course as identified by patients' physician, in terms of survival and unusual disease course that is appropriately medically documented.
  • Consent to participate in this study.

Exclusion criteria

  • Inability to understand the intent of the study.
  • Medical condition that would preclude participation in an interview session lasting 30-45 minutes.
  • Diagnosis of active psychosis or severe cognitive impairment confirmed by the patient's attending physician.

Treatment and study plan

Interview

Behavioral

Interview lasting approximately 30-45 minutes.

Primary outcomes

  1. Qualitative Data Collection: Patients' Experience of Exceptional Disease Course

    Time frame: 2 Years

Sponsors and collaborators

Lead sponsor

M.D. Anderson Cancer Center

Other

Registry information

Important dates

Study start
2007
Primary completion
2010
Study completion
2010
First posted
Oct 12, 2007
Registry last updated
Jul 30, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.